Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities:    
Net Income (Loss) $ (38,007) $ 8,314
Adjustments to reconcile net profit (loss) to cash used in operating activities    
Depreciation, amortization, and non-cash lease interest 6,677 3,634
Provision for doubtful accounts (866) 144
Reserve for excess and obsolete inventory 140 132
Change in fair value of warrant liabilities (314) (1,669)
Change in fair value of contingent earnout liability 7 (51,638)
Amortization (accretion) of (discounts) premiums on available-for-sale securities (1,304) 0
Stock-based compensation expense 6,046 10,334
Long-lived asset impairment 4,015 0
Changes in operating assets and liabilities, net of effects of businesses acquired    
Accounts receivable 3,017 68
Inventory (3,429) (9,076)
Prepaid expenses 1,862 2,583
Other current assets 35 (1,989)
Other assets (212) (652)
Accounts payable and accrued expenses (4,235) 501
Other current liabilities (352) (82)
Deferred revenue 330 (167)
Other long term liabilities (368) 0
Other non-current lease liabilities (3,742) (2,011)
Net cash used in operating activities (30,700) (41,574)
Investing Activities:    
Purchases of property and equipment (2,157) (1,531)
Cash paid for acquisitions, net of cash acquired 0 (2,033)
Purchases of available-for-sale securities (18,950) 0
Proceeds from sales and maturities of marketable securities 13,500 0
Net cash used in investing activities (7,607) (3,564)
Financing Activities:    
Acquisition Holdback Payment (250) 0
Proceeds from the exercise of common stock options 181 1,496
Taxes paid related to net share settlement of equity awards (146) (315)
Net cash provided by (used in) financing activities (215) 1,181
Effect of exchange rate changes on cash (62) 0
Net change in cash, cash equivalents, and restricted cash (38,584) (43,957)
Cash and cash equivalents and restricted cash    
Beginning of year 125,672 288,603
End of period 87,088 244,646
Supplemental disclosures of cash flow information    
Cash and cash equivalents 85,658 243,216
Restricted cash in other non-current assets 1,430 1,430
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 87,088 244,646
Non-cash financing and investing activities    
Purchase of property and equipment in accounts payable and accrued expenses 133 100
Common Stock issued for acquisitions 0 2,354
Additions to right of use assets and liabilities 0 36,246
Common stock issued to settle acquisition holdback $ 250 $ 0